Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Antonin LevyYoung Investigators EORTC Lung Cancer Group (YI EORTC LCG)

Abstract

Brain metastases (BM) are frequent in non-small cell lung cancer (NSCLC) patients, but there is a lack of evidence-based management of this patient group. We aimed to capture a snapshot of routine BM management in Europe to identify relevant research questions for future clinical trials. An EORTC Lung Cancer Group (LCG) online survey containing questions on NSCLC BM screening and treatment was distributed between 16/02/17 and 15/06/17 to worldwide EORTC LCG members, and through several European scientific societies in the thoracic oncology field. A total of 462 European physician responses (394 institutions) were analysed (radiation oncologist: 53% [n = 247], pulmonologist: 26% [n = 119], medical oncologist: 18% [n = 84]; 84% with >5 years' experience in NSCLC). Italy (18%, n = 85), Netherlands (15%, n = 68), UK (14%, n = 66), and France (12%, n = 55) contributed most. 393 physicians (85%) screened neurologically asymptomatic patients for BM at diagnosis (52% using magnetic resonance imaging). Most often screened patients were those with a driver mutation (MUT+; 51%, n = 234), stage III (63%, n = 289), and IV (43%, n = 199). 158 physicians (34%) used a prognostic classification to guide initial treatment decisions, and in 50%, ...Continue Reading

Citations

Jun 7, 2018·Journal of Medical Imaging and Radiation Oncology·Shalini K Vinod
Feb 14, 2019·Current Treatment Options in Neurology·Johannes KraftNicolaus Andratschke
May 28, 2019·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Valerio NardoneLuigi Pirtoli
Aug 16, 2019·Current Opinion in Oncology·Riccardo SoffiettiRoberta Rudà
Feb 20, 2020·Journal of Cancer Research and Clinical Oncology·Bruno MeduriUNKNOWN AIRO Giovani -Italian Association of Radiation Oncology-Young Members
May 8, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Michael G MilliganAileen B Chen
Sep 21, 2018·Frontiers in Oncology·Gokoulakrichenane LoganadaneAntonin Levy
Aug 25, 2018·Frontiers in Oncology·Ana TurkajSilvia Novello
Dec 10, 2019·Journal of Cancer Research and Clinical Oncology·Wang Li, Hong Yu
Jul 24, 2018·Therapeutic Advances in Neurological Disorders·Anna S Berghoff, Matthias Preusser
Jan 4, 2020·The European Respiratory Journal·Lizza E L HendriksThierry Berghmans
Nov 22, 2018·Frontiers in Oncology·Lizza E L HendriksAnne-Marie C Dingemans
Feb 1, 2020·Molecular Diversity·Disha PathakOm Silakari
Jan 14, 2021·International Journal of Molecular Sciences·Agnieszka Rybarczyk-KasiuchniczKatarzyna Stencel
Aug 24, 2020·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·F DhermainA Tallet
Sep 15, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Antonin LevyUNKNOWN EORTC Lung Cancer Group (EORTC LCG)
Nov 2, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonin LevyUNKNOWN EORTC Lung Cancer Group (EORTC LCG)
Aug 11, 2021·Cancer Medicine·Mohammed SafiJiwei Liu
Nov 23, 2021·The British Journal of Radiology·Sophie H A E DerksMarion Smits

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.